Evidence map›Paper›PMID 42074223›Full record

ReviewInternational journal of molecular sciences2026

Construction Strategies and Advances in Bone Marrow Microphysiological Systems.

Tian Lin, Haodong Zhong, Qianyi Niu, Ruiqiu Zhang, Manman Zhao, Xiaobing Zhou

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tian LinNational Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 102600, China.
Haodong ZhongNational Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 102600, China.ORCID 0009-0007-3060-3362
Qianyi NiuNational Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 102600, China.
Ruiqiu ZhangNational Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 102600, China.
Manman ZhaoNational Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 102600, China.
Xiaobing ZhouNational Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 102600, China.

Funding

Open Project of the National Key Laboratory of Drug Regulatory Science 2025SKLDRS0326
6 · The paper itself

Abstract

Bone marrow(BM) is the primary site of hematopoiesis, supporting the self-renewal and differentiation of hematopoietic stem cells (HSCs). Its function depends on a highly complex microenvironment composed of stromal cells, vascular networks, extracellular matrix components, and dynamic biophysical signals. Traditional two-dimensional culture systems and animal models fail to adequately recapitulate the spatial architecture and dynamic regulatory processes of the human bone marrow niche, thereby limiting in-depth investigations into hematopoietic regulatory mechanisms, disease pathogenesis, and drug-induced bone marrow toxicity. In recent years, advances in microphysiological systems (MPS) have provided novel engineering approaches for the in vitro reconstruction of the bone marrow microenvironment. This review systematically summarizes current construction strategies for bone marrow MPS, including three-dimensional self-organized bone marrow organoids and microfluidic bone marrow-on-a-chip platforms. Particular attention is given to the roles of key cellular components, biomaterial scaffolds, vascularized architectures, and dynamic perfusion systems in biomimetic bone marrow engineering. In addition, we discuss strategies for constructing more complex models, such as vascular niches, vascularized bone tissue constructs, and bone metastasis models. Bone marrow MPS more faithfully recapitulate the hematopoietic microenvironment and provide a physiologically relevant in vitro platform for hematopoietic research, disease modeling, and drug evaluation, thereby supporting future advances in precision and regenerative medicine.

Indexed as

Bone MarrowAnimalsHematopoiesisHematopoietic Stem CellsHumansMicrophysiological SystemsStem Cell NicheTissue Engineeringbone marrowhematopoietic stem cellmicrophysiological systemorganoidorgan-on-a-chip

Identifiers

PMID42074223
PMCPMC13116155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.